Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

CDIN1-Codanin-1 complex defective in congenital dyserythropoietic anaemia type I is an RNA nuclease.

Nature communications·2026
Same author

Loop extrusion by cohesin plays a role in enhancer-activated gene expression early in differentiation.

Nature communications·2026
Same author

LSD1 inhibition ameliorates congenital dyserythropoietic anemia type II.

Science translational medicine·2026
Same author

A functional overlap between actively transcribed genes and chromatin insulator elements.

The EMBO journal·2026
Same author

ATRX loss couples genome instability at a G-rich repeat to dysregulation of human alpha-globin expression.

Nature communications·2026
Same author

Lipid metabolism transcriptomic signature of defective erythropoiesis in Diamond Blackfan anemia syndrome.

Blood advances·2026
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: May 29, 2026

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

La talasemia es la talasemia.

Douglas R Higgs1, James Douglas Engel, George Stamatoyannopoulos

  • 1Medical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK. doug.higgs@imm.ox.ac.uk

Lancet (London, England)
|September 13, 2011
PubMed
Resumen
Este resumen es generado por máquina.

La talasemia, un trastorno sanguíneo genético común, afecta a 60.000 recién nacidos al año, principalmente en las regiones tropicales. La investigación se centra en nuevas terapias como la terapia génica para mejorar la síntesis de beta-globina en adultos y reducir la dependencia de las transfusiones.

Más Videos Relacionados

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Videos de Experimentos Relacionados

Last Updated: May 29, 2026

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Área de la Ciencia:

  • Genética La genética.
  • Biología Molecular Biología Molecular
  • Hematología Hematología.

Sus antecedentes:

  • La talasemia es un trastorno genético prevalente en todo el mundo que afecta la síntesis de hemoglobina.
  • Tiene un impacto desproporcionado en las poblaciones de las regiones tropicales y subtropicales.
  • Los tratamientos actuales se basan en la atención de apoyo, incluidas las transfusiones de sangre y la quelación de hierro.

Objetivo del estudio:

  • Revisar los avances recientes en la comprensión de las bases moleculares y celulares de la talasemia.
  • Explorar nuevas estrategias terapéuticas dirigidas a aumentar la expresión génica fetal.
  • Discutir el potencial de las terapias génicas y celulares para la talasemia.

Principales métodos:

  • Revisión de los mecanismos moleculares y celulares de la expresión génica de la globina.
  • Análisis de agentes farmacológicos emergentes dirigidos a la regulación génica de las globinas.
  • Evaluación del primer ensayo de terapia génica para la talasemia.

Principales resultados:

  • Progreso significativo en la comprensión de la regulación génica de la globina en la talasemia.
  • El desarrollo de agentes farmacológicos dirigidos es prometedor.
  • Los primeros ensayos de terapia génica indican potencial para mejorar los resultados del tratamiento.

Conclusiones:

  • Las nuevas vías terapéuticas, incluidas las terapias génicas y celulares, ofrecen esperanza más allá de la atención de apoyo tradicional.
  • La investigación continua sobre los mecanismos moleculares es crucial para desarrollar tratamientos efectivos para la talasemia.
  • La colaboración internacional impulsa la innovación en el manejo de esta enfermedad genética generalizada.